|
⚲
|
| Keyboard |
| Halozyme Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001159036 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001159036] | |
| 10-Q | [0001159036] | |
| 3 | [0001159036] | |
| 4 | [0001159036] | |
| 5 | [0001159036] | |
| 8-K | [0001159036] | |
| SC 13G | [0001159036] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-10 | Option exercise | 1,546 | $33.51 | 51,806 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-10 | Option exercise | 1,546 | $33.51 | 51,806 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-10 | Sell | 8,857 | $67.64 | 599,087 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-09 | Option exercise | 20,000 | $33.51 | 670,200 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-09 | Sell | 2,100 | $68.25 | 143,325 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-09 | Option exercise | 20,000 | $33.51 | 670,200 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-09 | Sell | 17,900 | $67.75 | 1,212,725 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-04 | Option exercise | 10,000 | $12.07 | 120,700 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-04 | Option exercise | 10,000 | $12.07 | 120,700 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-04 | Sell | 2,671 | $70.95 | 189,507 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-04 | Sell | 7,329 | $69.94 | 512,590 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-03 | Sell | 6,519 | $69.33 | 451,962 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-03 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-03 | Sell | 13,481 | $68.85 | 928,167 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-03 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2026-03-02 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Option exercise | 20,000 | $12.07 | 241,400 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Sell | 15,322 | $69.80 | 1,069,476 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Sell | 4,100 | $69.20 | 283,720 |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2026-03-02 | Sell | 578 | $70.46 | 40,726 |
| showing 20 of 200 most recent transactions | |||||